Ceftriaxone treatment affects the levels of GLT1 and ENT1 as well as ethanol intake in alcohol-preferring rats

scientific article published on 27 July 2013

Ceftriaxone treatment affects the levels of GLT1 and ENT1 as well as ethanol intake in alcohol-preferring rats is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S12031-013-0064-Y
P932PMC publication ID3797852
P698PubMed publication ID23893122

P2093author name stringDoo-Sup Choi
Moonnoh R Lee
Youssef Sari
Sai N Sreemantula
P2860cites workCeftriaxone restores glutamate homeostasis and prevents relapse to cocaine seekingQ24656626
Glutamate uptakeQ28190140
Limbic activation during cue-induced cocaine cravingQ28369526
What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience?Q29618655
Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortexQ29619998
ENT1 regulates ethanol-sensitive EAAT2 expression and function in astrocytesQ34035612
Ceftriaxone-induced up-regulation of cortical and striatal GLT1 in the R6/2 model of Huntington's diseaseQ34053585
Selective loss of glial glutamate transporter GLT‐1 in amyotrophic lateral sclerosisQ34300016
Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression.Q34382218
Regulation of ethanol-sensitive EAAT2 expression through adenosine A1 receptor in astrocytesQ34671783
Type 1 equilibrative nucleoside transporter regulates ethanol drinking through accumbal N-methyl-D-aspartate receptor signalingQ34958402
Ceftriaxone, a beta-lactam antibiotic, reduces ethanol consumption in alcohol-preferring ratsQ35015226
Role of excitatory amino acid transporter-2 (EAAT2) and glutamate in neurodegeneration: opportunities for developing novel therapeutics.Q35087565
N-methyl-D-aspartate glutamate receptors and alcoholism: reward, dependence, treatment, and vulnerabilityQ35153745
Glutamate systems in cocaine addictionQ35690222
Adenosine and glutamate signaling in neuron-glial interactions: implications in alcoholism and sleep disordersQ35951700
Neuroimmunophilin GPI-1046 reduces ethanol consumption in part through activation of GLT1 in alcohol-preferring ratsQ36422300
Up-regulation of GLT1 expression increases glutamate uptake and attenuates the Huntington's disease phenotype in the R6/2 mouseQ36713909
Ceftriaxone, a beta-lactam antibiotic, attenuates relapse-like ethanol-drinking behavior in alcohol-preferring ratsQ36853227
Effects of ceftriaxone on the acquisition and maintenance of ethanol drinking in peri-adolescent and adult female alcohol-preferring (P) ratsQ36855000
Upregulation of GLT1 attenuates cue-induced reinstatement of cocaine-seeking behavior in ratsQ37332208
Excitotoxicity and neurodegeneration in amyotrophic lateral sclerosis.Q41341457
Ethanol exposure differentially alters central monoamine neurotransmission in alcohol-preferring versus -nonpreferring rats.Q41608536
Ethanol alters glutamate but not adenosine uptake in rat astrocytes: evidence for protein kinase C involvementQ43962329
Functional changes of glial glutamate transporter GLT-1 during ischemia: an in vivo study in the hippocampal CA1 of normal mice and mutant mice lacking GLT-1.Q44540557
The type 1 equilibrative nucleoside transporter regulates ethanol intoxication and preference.Q44982517
Transgenic expression of human equilibrative nucleoside transporter 1 in mouse neuronsQ46119603
Ethanol exposure decreases glutamate uptake in the nucleus accumbensQ46381488
A postsynaptic interaction between dopamine D1 and NMDA receptors promotes presynaptic inhibition in the rat nucleus accumbens via adenosine release.Q48658263
Glutamate transport is downregulated in the cerebral cortex of alcohol-preferring rats.Q49018776
Regional deafferentation down-regulates subtypes of glutamate transporter proteinsQ71832642
Regulation of glutamate uptake in astrocytes continuously exposed to ethanolQ73994164
P433issue3
P921main subjectceftriaxoneQ421713
P304page(s)779-787
P577publication date2013-07-27
P1433published inJournal of Molecular NeuroscienceQ15708870
P1476titleCeftriaxone treatment affects the levels of GLT1 and ENT1 as well as ethanol intake in alcohol-preferring rats
P478volume51

Reverse relations

cites work (P2860)
Q28068256A Genetic Animal Model of Alcoholism for Screening Medications to Treat Addiction
Q89441164Alcohol and Cocaine Exposure Modulates ABCB1 and ABCG2 Transporters in Male Alcohol-Preferring Rats
Q41664989Alcohol consumption increases basal extracellular glutamate in the nucleus accumbens core of Sprague-Dawley rats without increasing spontaneous glutamate release.
Q36037560Amoxicillin and amoxicillin/clavulanate reduce ethanol intake and increase GLT-1 expression as well as AKT phosphorylation in mesocorticolimbic regions.
Q26996339Astrocytic dysfunction and addiction: consequences of impaired glutamate homeostasis
Q48027529Astroglia, Glutamatergic Transmission and Psychiatric Diseases
Q30578263Attenuation of ethanol withdrawal by ceftriaxone-induced upregulation of glutamate transporter EAAT2.
Q47437172Beyond the "First Hit": Marked Inhibition by N-Acetyl Cysteine of Chronic Ethanol Intake But Not of Early Ethanol Intake. Parallel Effects on Ethanol-Induced Saccharin Motivation.
Q91789963Caffeine induces neurobehavioral effects through modulating neurotransmitters
Q35161340Ceftriaxone and cefazolin attenuate the cue-primed reinstatement of alcohol-seeking
Q35956322Ceftriaxone attenuates ethanol drinking and restores extracellular glutamate concentration through normalization of GLT-1 in nucleus accumbens of male alcohol-preferring rats
Q36581692Clavulanic acid enhances glutamate transporter subtype I (GLT-1) expression and decreases reinforcing efficacy of cocaine in mice
Q34021956Clavulanic acid reduces rewarding, hyperthermic and locomotor-sensitizing effects of morphine in rats: a new indication for an old drug?
Q28828473Development and evaluation of a calcium alginate based oral ceftriaxone sodium formulation
Q35077751Effectiveness of Ceftriaxone Treatment in Preventing Relapse-like Drinking Behavior Following Long-term Ethanol Dependence in P Rats
Q35417634Effects of (R)-(-)-5-methyl-1-nicotinoyl-2-pyrazoline on glutamate transporter 1 and cysteine/glutamate exchanger as well as ethanol drinking behavior in male, alcohol-preferring rats.
Q48416598Effects of Administered Ethanol and Methamphetamine on Glial Glutamate Transporters in Rat Striatum and Hippocampus
Q36829679Effects of Amoxicillin and Augmentin on Cystine-Glutamate Exchanger and Glutamate Transporter 1 Isoforms as well as Ethanol Intake in Alcohol-Preferring Rats
Q37273362Effects of Ceftriaxone on Glial Glutamate Transporters in Wistar Rats Administered Sequential Ethanol and Methamphetamine
Q93337978Effects of Clavulanic Acid Treatment on Reinstatement to Methamphetamine, Glial Glutamate Transporters, and mGluR 2/3 Expression in P Rats Exposed to Ethanol
Q34426947Effects of MS-153 on chronic ethanol consumption and GLT1 modulation of glutamate levels in male alcohol-preferring rats.
Q35533496Effects of ampicillin, cefazolin and cefoperazone treatments on GLT-1 expressions in the mesocorticolimbic system and ethanol intake in alcohol-preferring rats.
Q35738010Effects of ceftriaxone on GLT1 isoforms, xCT and associated signaling pathways in P rats exposed to ethanol
Q34250509Effects of ceftriaxone on ethanol intake: a possible role for xCT and GLT-1 isoforms modulation of glutamate levels in P rats
Q48390347Effects of orally administered Augmentin on glutamate transporter 1, cystine-glutamate exchanger expression and ethanol intake in alcohol-preferring rats
Q53333507Effects of repeated cocaine exposure and withdrawal on voluntary ethanol drinking, and the expression of glial glutamate transporters in mesocorticolimbic system of P rats.
Q40502974Equilibrative nucleoside transporter ENT1 as a biomarker of Huntington disease
Q30367006Ethanol-Associated Changes in Glutamate Reward Neurocircuitry: A Minireview of Clinical and Preclinical Genetic Findings.
Q90473578General Pathophysiology of Astroglia
Q43076075Glial and neuroinflammatory targets for treating substance use disorders
Q38729846Glutamate Transport: A New Bench to Bedside Mechanism for Treating Drug Abuse
Q99201953Influence of n-acetylcysteine maintenance on the pharmacodynamic effects of oral ethanol
Q46487290Intracerebral Stem Cell Administration Inhibits Relapse-like Alcohol Drinking in Rats
Q90884465Pregabalin: Potential for Addiction and a Possible Glutamatergic Mechanism
Q39142990Rat animal models for screening medications to treat alcohol use disorders.
Q34999412Redox-based epigenetic status in drug addiction: a potential contributor to gene priming and a mechanistic rationale for metabolic intervention
Q47789766Regulation of glutamate transporter 1 (GLT-1) gene expression by cocaine self-administration and withdrawal
Q35110324Repeated cycles of chronic intermittent ethanol exposure increases basal glutamate in the nucleus accumbens of mice without affecting glutamate transport
Q64118653Repurposing of the β-Lactam Antibiotic, Ceftriaxone for Neurological Disorders: A Review
Q26750910Role of astrocytic glutamate transporter in alcohol use disorder
Q33912290Role of glutamate transporter 1 in the attenuation of alcohol intake
Q47860319Sex and Adolescent Ethanol Exposure Influence Pavlovian Conditioned Approach.
Q37059772Signals from the Fourth Dimension Regulate Drug Relapse
Q27002488Targeting glutamate uptake to treat alcohol use disorders
Q37062547The Nucleus Accumbens: Mechanisms of Addiction across Drug Classes Reflect the Importance of Glutamate Homeostasis
Q38589482Translational potential of astrocytes in brain disorders
Q47920494β-Lactamase inhibitor, clavulanic acid, attenuates ethanol intake and increases glial glutamate transporters expression in alcohol preferring rats

Search more.